PSIL
PSIL
About AdvisorShares Psychedelics ETF
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more...
About AdvisorShares Psychedelics ETF
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ATAI | Atai Beckley Inc. | 13.84% | 891.78K | $6.44M |
 DFTX | Definium Therapeutics, Inc. | 11.92% | 125.26K | $5.55M |
 CMPS | COMPASS Pathways plc | 10.40% | 391.79K | $4.84M |
 NRXP | NRx Pharmaceuticals, Inc. | 6.24% | 680.10K | $2.90M |
 RLMD | Relmada Therapeutics, Inc. | 5.10% | 452.94K | $2.37M |
 GHRS | GH Research PLC | 4.79% | 77.67K | $2.23M |
 ABBV | AbbVie Inc. | 4.35% | 7.96K | $2.03M |
 DRUG | Bright Minds Biosciences Inc. | 4.33% | 26.49K | $2.02M |
 ALKS | Alkermes plc | 4.26% | 37.60K | $1.98M |
 HELP | Cybin Inc. Common Stock | 4.01% | 291.07K | $1.36M |
 JNJ | Johnson & Johnson | 3.76% | 6.91K | $1.75M |
 SUPN | Supernus Pharmaceuticals, Inc. | 2.94% | 28.49K | $1.37M |
 NEUP | Neuphoria Therapeutics Inc. | 1.92% | 261.00K | $891.30K |
 QNTM | Quantum BioPharma Ltd. | 1.68% | 241.03K | $780.93K |
 OPTH | Optimi Health Corp. | 1.36% | 126.72K | $634.86K |
 LLY | Eli Lilly and Company | 1.27% | 500 | $589.55K |
 KTTA | Pasithea Therapeutics Corp. | 0.94% | 967.55K | $435.40K |
 PBM | Psyence Biomedical Ltd. | 0.83% | 126.08K | $387.08K |
 SILO | Silo Pharma, Inc. | 0.81% | 77.99K | $379.05K |
 IXHL | Incannex Healthcare Limited | 0.43% | 62.81K | $199.11K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Canada
Ireland
AustraliaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Canada Ireland AustraliaHoldings (Top 20)
ATAI
Atai Beckley Inc.
DFTX
Definium Therapeutics, Inc.
CMPS
COMPASS Pathways plc
NRXP
NRx Pharmaceuticals, Inc.
RLMD
Relmada Therapeutics, Inc.
GHRS
GH Research PLC
ABBV
AbbVie Inc.
DRUG
Bright Minds Biosciences Inc.
ALKS
Alkermes plc
HELP
Cybin Inc. Common Stock
JNJ
Johnson & Johnson
SUPN
Supernus Pharmaceuticals, Inc.
NEUP
Neuphoria Therapeutics Inc.
QNTM
Quantum BioPharma Ltd.
OPTH
Optimi Health Corp.
LLY
Eli Lilly and Company
KTTA
Pasithea Therapeutics Corp.
PBM
Psyence Biomedical Ltd.
SILO
Silo Pharma, Inc.
IXHL
Incannex Healthcare Limited